top of page
Dr. Roxana Mehran on the BackTable Cardiology Podcast

Dr. Roxana Mehran

Interventional Cardiologist

1 Podcast on BackTable

Dr. Roxana Mehran is an interventional cardiologist and Professor of Medicine at Mount Sinai, and the incoming President elect of the American College of Cardiology (ACC).

Learn from the experiences and expertise of Dr. Roxana Mehran and other leading voices in your specialty on the BackTable app.

The Role of Cangrelor in Modern Interventional Cardiology: Practice, Guidelines & Data Review
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Cardiology

Episode # 22  •  27 Jan 2026

The Role of Cangrelor in Modern Interventional Cardiology: Practice, Guidelines & Data Review

Fast acting and reversible: IV cangrelor offers rapid on, rapid off P2Y12 platelet inhibition that sidesteps oral absorption delays. In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo welcomes renowned interventional cardiologist Dr. Roxana Mehran, incoming President elect of the American College of Cardiology (ACC), to discuss the emerging role of cangrelor and its implications on current cardiology practice.

This podcast is supported by an educational grant from Cheisi.

More from Dr. Roxana Mehran

About

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI, is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute at the Icahn School of Medicine at Mount Sinai. Dr. Mehran completed her internal medicine residency, serving as Chief Medical Resident at the University of Connecticut, followed by fellowships in Cardiovascular Disease and Interventional Cardiology at Mount Sinai Medical Center.

Roxana Mehran, MD, is an internationally renowned interventional cardiologist, clinical research expert, and trialist in the field of cardiovascular disease. She is among the most prolific researchers in the United States and is a globally respected leader of an academic research center focused on designing and implementing randomized clinical trials, outcomes research projects, and high-impact academic publications. She has focused on personalized medicine and developed individual risk scores for bleeding and acute kidney injury, and she regularly contributes to the development of clinical guidelines.
Dr. Mehran currently serves as a member of the Board of Trustees of the American College of Cardiology and as Vice President (2025–2026). With over 3,000 publications, she has been listed by Clarivate Analytics among the Most Cited Researchers – Top 1% and The World’s Most Influential Scientific Minds (Thomson Reuters) for the past ten consecutive years, ranking among the top 50 researchers worldwide.

Dr. Mehran leads The Lancet Commission on Women’s Cardiovascular Diseases, which aims to bridge gaps in scientific discovery, clinical trials, and care for women with cardiovascular disease. She serves as Director of the Women’s Heart and Vascular Center at Mount Sinai Heart, spearheading a program designed to meet the unique needs of women’s cardiovascular health. She also founded Women as One, a not-for-profit organization dedicated to advancing opportunities for women in medicine.

Dr. Mehran is the recipient of numerous honors, including the Ellis Island Medal of Honor; the European Society of Cardiology (ESC) Silver Medal; the ESC Andreas Grüntzig Lecture Plaque; the Women in Cardiology Mentoring Award; the CRF Pulse-Setter Champion Award; the Jacobi Medallion from the Icahn School of Medicine at Mount Sinai; and, most recently, the ESC Gold Medal (2025) and the AHA Laennec Master Clinician Award (2025).

Visit Mount Sinai to learn more about Dr. Roxana Mehran.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page